Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Summary

This was a proof-of-concept study to evaluate the efficacy of LOU064 in patients with inadequately controlled asthma. All subjects were randomized with 3:2 ratio to receive LOU064 100 mg once daily or LOU064 matching placebo for 12 weeks with standard background therapy of budesonide 80 µg/formoterol 4.5 µg two inhalations twice a day (b.i.d).

Timeline

Start

2019-07-18

Primary completion

2020-04-27

Completion

2020-04-27

Drugs

Indications